.svg){kind=small}
Committed to Patient Safety Through Expert Pharmacovigilance
At Richmond Pharmacology, patient safety is at the heart of every clinical trial. Our dedicated Pharmacovigilance (PV) team ensures that all safety data are captured, assessed and reported in compliance with global regulatory standards.
Pharmacovigilance is the science of monitoring and preventing adverse effects. It safeguards trial participants, ensures regulators and sponsors can act on emerging data, and underpins confidence in new medicines.
Our PV processes have been developed to the highest standards, ensuring no important safety event is missed. Every adverse event is recorded, reviewed and reported.
Our Approach
Recording and evaluation of all adverse events, including those unrelated to the trial
Rigorous review of serious adverse events by our safety team and Principal Investigators
Tailored processes depending on the complexity of the trial, always aligned with regulatory requirements
Ethical governance in line with international safety frameworks
Close collaboration with investigators, doctors and sponsors to ensure patient protection
Commitment to Global Standards
ICH Guidelines
CIOMS VI Working Group
The Medicines for Human Use (Clinical Trials) Regulations
Hear from our sponsors
.svg){kind=small}
Expert Team
Our Pharmacovigilance team includes experienced Drug Safety Monitors, safety physicians and clinical staff. Working together with Doctors, they bring expertise in early-phase research and ensure the highest standards of participant safety and regulatory compliance.
Our Offering Includes
Dedicated trial-specific PV systems
Comprehensive adverse event collection and tracking
Timely safety reporting to sponsors, regulators and ethics committees
Signal detection and escalation procedures
Oversight and safety governance by Principal Investigators
PV training for trial staff to maintain compliance and awareness
.avif)
Latest news
Patient safety is not an afterthought. Explore our new infographic!
Events
JSCPT 2025
